Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Indian Regulator Warns Pharma Firms Not To Miss Expert Panel Meetings

This article was originally published in SRA

Executive Summary

The failure of certain drug companies to turn up at meetings organized to review their products by subject matter experts has irked the Drugs Controller General of India, who has warned that such unexplained absences are "viewed seriously"1.